Scribd Logo
Upload

Welcome to Scribd!

  • 29 views

    Hosp Ops II Week 3 Questions 1

    Uploaded by

    api-650133203
    This document contains answers to questions about common infections and appropriate treatment recommendations. For a urinary tract infection (UTI), it recommends common causative bacteria of E. coli and appropriate antibiotic treatment of 5 days of nitrofurantoin for an uncomplicated UTI, and 7-14 days of fluoroquinolones or third-generation cephalosporins for pyelonephritis. For coverage of Pseudomonas aeruginosa, it lists several antibiotic classes including piperacillin/tazobactam, cefepime, aminoglycosides, ciprofloxacin, and carbapenems. For a patient with both MRSA wound infection and C. difficile infection,

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Hosp Ops II Week 3 Questions 1

    Uploaded by

    api-650133203
    29 views2 pages
    This document contains answers to questions about common infections and appropriate treatment recommendations. For a urinary tract infection (UTI), it recommends common causative bacteria of E. coli and appropriate antibiotic treatment of 5 days of nitrofurantoin for an uncomplicated UTI, and 7-14 days of fluoroquinolones or third-generation cephalosporins for pyelonephritis. For coverage of Pseudomonas aeruginosa, it lists several antibiotic classes including piperacillin/tazobactam, cefepime, aminoglycosides, ciprofloxacin, and carbapenems. For a patient with both MRSA wound infection and C. difficile infection,

    Original Title

    hosp ops ii week 3 questions 1

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document contains answers to questions about common infections and appropriate treatment recommendations. For a urinary tract infection (UTI), it recommends common causative bacteria of E. coli and appropriate antibiotic treatment of 5 days of nitrofurantoin for an uncomplicated UTI, and 7-14 days of fluoroquinolones or third-generation cephalosporins for pyelonephritis. For coverage of Pseudomonas aeruginosa, it lists several antibiotic classes including piperacillin/tazobactam, cefepime, aminoglycosides, ciprofloxacin, and carbapenems. For a patient with both MRSA wound infection and C. difficile infection,

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    29 views2 pages

    Hosp Ops II Week 3 Questions 1

    Uploaded by

    api-650133203
    This document contains answers to questions about common infections and appropriate treatment recommendations. For a urinary tract infection (UTI), it recommends common causative bacteria of E. coli and appropriate antibiotic treatment of 5 days of nitrofurantoin for an uncomplicated UTI, and 7-14 days of fluoroquinolones or third-generation cephalosporins for pyelonephritis. For coverage of Pseudomonas aeruginosa, it lists several antibiotic classes including piperacillin/tazobactam, cefepime, aminoglycosides, ciprofloxacin, and carbapenems. For a patient with both MRSA wound infection and C. difficile infection,

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    Hospital Operations II Rotation

    Franciscan Health Lafayette


    Question Packet #3
    ANSWERS
    1. What bacteria most commonly cause a urinary tract infection? What empiric antibiotic therapy do you
    recommend including length of therapy for the treatment of an uncomplicated UTI and
    pyelonephritis/complicated UTI?
     Gram-negative bacteria typically cause UTIs
    o More than 95% of uncomplicated UTIs are monobacterial
    o Most common pathogen = E. coli (75-95%), followed by Klebsiella pneumonia, Staphylococcus
    saprophyticus, Enterococcus faecalis, group B streptococci
    o Frequent cause of complicated UTI = Proteus mirabilis, pseudomonas aeruginosa, and
    enterococcus; these are more commonly isolated in hospitals and long-term care facilities

    Acute Uncomplicated UTI Treatment Pyelonephritis Treatment


    Outpatient Therapy:
     Ciprofloxacin 500 mg PO BID x 7 days
    Nitrofurantoin 100 mg PO BID x 5 days  Levofloxacin 750 mg PO QD x 5 days
    o If local resistance is > 10%, give
    Bactrim DS PO BID x 10 days ceftriaxone 1 gram IV
    Inpatient Therapy:
    Fosfomycin 3 grams PO once  Ciprofloxacin 400 mg IV BID x 7 days
     Levofloxacin 500 mg IV QD x 7 days
     Ceftriaxone 1-gram IV Q24H x 14 days

    2. What antibiotics provide empiric coverage against most strains of Pseudomonas aeruginosa?

    Piperacillin/Tazobactam Cefepime Ceftazidime

    Aminoglycosides Ciprofloxacin Levofloxacin

    Ceftolazone/Tazobactam Ceftazidime/Avibactam Carbapenems


    (Excluding Ertapenem)

    3. An 85 year old woman was admitted for a wound infection on her right foot. Cultures revealed that the wound
    had MRSA. The ID physician started her on vancomycin IVPB. She has also had severe diarrhea and tested
    positive for C. difficile and the hospitalist ordered vancomycin 250mg PO four times a day. Would you call the
    hospitalist or the infectious disease doctor about her being on both PO and IV vancomycin? Why or why not?
     No, then patient will need both medications to treat both of her infections. Clostridioides difficile must
    be treated with PO vancomycin and PO vancomycin is not adequate coverage for the MRSA within the
    patient’s wound.
    Hospital Operations II Rotation
    Franciscan Health Lafayette
    Question Packet #3

    4. A nurse calls the pharmacy asking which pneumococcal vaccine she should give a 68-year-old patient with a history of diabetes and hypertension. The
    patient thinks he received a pneumonia vaccine 3 years ago. Does the patient need to be re-vaccinated? If yes, which pneumococcal vaccine should be
    administered?
     It depends on the vaccine the patient previously had.
    o If the patient previously received Prevnar 20, they do not need another vaccine
    o If the patient previously received Prevnar 13 or Pneumovax 23 ≥ 1 year ago, they would need the Prevnar 20 vaccine

    You might also like